Levine James E. 4
4 · Cardiff Oncology, Inc. · Filed Dec 18, 2024
Insider Transaction Report
Form 4
Levine James E.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2024-12-16$3.83/sh+2,564$9,820→ 62,564 total(indirect: By Spouse) - Purchase
Common Stock
2024-12-18$5.00/sh+2,400$12,000→ 67,716 total(indirect: By Spouse) - Purchase
Common Stock
2024-12-17$5.42/sh+2,752$14,905→ 65,316 total(indirect: By Spouse)